A Phase I Extension Trial of Repeated Infusions of ISF35
Phase 1
Completed
- Conditions
- Chronic Lymphocytic Leukemia
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2008-10-31
- Lead Sponsor
- Memgen, LLC
- Target Recruit Count
- 4
- Registration Number
- NCT00783588
- Locations
- 🇺🇸
University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
Phase 1
Completed
- Conditions
- Chronic Lymphocytic Leukemia
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Memgen, LLC
- Target Recruit Count
- 9
- Registration Number
- NCT00779883
- Locations
- 🇺🇸
University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
Phase 1
Completed
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- Biological: ISF35
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- Memgen, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT00772486
- Locations
- 🇺🇸
University of California, San Diego Moores Cancer Center, San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath